| NASDAQ (usa) |
 |
6715.56 | -12.11 | -0.18% |
| FTSE 100 (london) |
|
7487.96 | -5.12 | -0.07% |
| DAX (german) |
 |
13465.51 | 235.94 | 1.78% |
| NIKKEI 225 (japan) |
|
22420.08 | 408.47 | 1.86% |
| Hang - Seng (hong kong) |
|
28594.06 | 348.52 | 1.23% |
| NIFTY - 50 (india) | ||||
| Straits Times (singapore) |
|
3391.61 | 17.53 | 0.52% |
| KOSPI (korea) |
|
2556.47 | 33.04 | 1.31% |
| All Ordinaries (australia) |
|
6005.30 | 28.90 | 0.48% |
| BOVESPA (brazil) |
|
74092.76 | -215.73 | -0.29% |
Invitae Corporation (NYSE: NVTA)
NVTA Technical Analysis
5
| As on 9th Jun 2023 NVTA STOCK Price closed @ 1.18 and we RECOMMEND Strong Sell for LONG-TERM with Stoploss of 5.67 & Strong Sell for SHORT-TERM with Stoploss of 11.64 we also expect STOCK to react on Following IMPORTANT LEVELS. |
NVTASTOCK Price
| Open | 1.20 | Change | Price | % |
| High | 1.30 | 1 Day | -0.02 | -1.67 |
| Low | 1.17 | 1 Week | 0.11 | 10.28 |
| Close | 1.18 | 1 Month | -0.18 | -13.24 |
| Volume | 5143800 | 1 Year | -16.06 | -93.16 |
| 52 Week High 17.24 | 52 Week Low 1.05 | ||||
NYSE USA Most Active Stocks
| DDR | 15.44 | -4.46% |
| NIO | 7.73 | -0.77% |
| TWTR | 53.70 | 0.66% |
| CVNA | 19.07 | -21.30% |
| BACA-U | 302.00 | 0.67% |
| PLTR | 15.02 | -1.12% |
| F | 13.74 | 1.18% |
| CS | 0.89 | 1.14% |
| RPAI | 13.15 | -3.17% |
| AUY | 5.85 | -0.68% |
NYSE USA Top Gainers Stocks
NYSE USA Top Losers Stocks
| NVTA Daily Charts |
NVTA Intraday Charts |
Whats New @ Bazaartrend |
NVTA Free Analysis |
|
|
NVTA Important Levels Intraday
| RESISTANCE | 1.43 |
| RESISTANCE | 1.35 |
| RESISTANCE | 1.30 |
| RESISTANCE | 1.25 |
| SUPPORT | 1.11 |
| SUPPORT | 1.06 |
| SUPPORT | 1.01 |
| SUPPORT | 0.93 |
NVTA Forecast April 2024
| 4th UP Forecast | 10.08 |
| 3rd UP Forecast | 7.23 |
| 2nd UP Forecast | 5.46 |
| 1st UP Forecast | 3.7 |
| 1st DOWN Forecast | -1.34 |
| 2nd DOWN Forecast | -3.1 |
| 3rd DOWN Forecast | -4.87 |
| 4th DOWN Forecast | -7.72 |
NVTA Weekly Forecast
| 4th UP Forecast | 6.07 |
| 3rd UP Forecast | 4.50 |
| 2nd UP Forecast | 3.53 |
| 1st UP Forecast | 2.56 |
| 1st DOWN Forecast | -0.20 |
| 2nd DOWN Forecast | -1.17 |
| 3rd DOWN Forecast | -2.14 |
| 4th DOWN Forecast | -3.71 |
NVTA Forecast2024
| 4th UP Forecast | 33.46 |
| 3rd UP Forecast | 23.11 |
| 2nd UP Forecast | 16.71 |
| 1st UP Forecast | 10.31 |
| 1st DOWN Forecast | -7.95 |
| 2nd DOWN Forecast | -14.35 |
| 3rd DOWN Forecast | -20.75 |
| 4th DOWN Forecast | -31.1 |
Invitae Corporation ( NYSE USA Symbol : NVTA )
Sector : Healthcare And Other Stocks in Same Sector
Sector : Healthcare And Other Stocks in Same Sector
NVTA Business Profile
Invitae Corporation, a medical genetics company, integrates genetic information into healthcare decision-making by clinicians and patients in the United States, Canada, and internationally. The company offers genetic tests in various clinical areas, including hereditary cancer, cardiology, neurology, pediatrics, oncology, metabolic conditions, and rare diseases. It serves patients, healthcare providers, biopharma companies, and other partners. It has a collaboration with Pacific Biosciences of California, Inc. to develop a production-scale high-throughput HiFi sequencing platform. The company was formerly known as Locus Development, Inc. and changed its name to Invitae Corporation in 2012. Invitae Corporation was founded in 2010 and is headquartered in San Francisco, California. Address: 1400 16th Street, San Francisco, CA, United States, 94103
© 2005-2023 BazaarTrend.com All rights reserved.
Data and information is provided for informational purposes only, and is not intended for trading purposes.
Neither BazaarTrend.com website nor any of its promoters shall be liable for any errors
or delays in the content, or for any actions taken in reliance thereon. Your use of this website constitutes
acceptance of our Terms Of Service
Data and information is provided for informational purposes only, and is not intended for trading purposes.
Neither BazaarTrend.com website nor any of its promoters shall be liable for any errors
or delays in the content, or for any actions taken in reliance thereon. Your use of this website constitutes
acceptance of our Terms Of Service